Medindia LOGIN REGISTER
Medindia
Advertisement

Merrimack Reports First Quarter 2019 Financial Results

Friday, May 10, 2019 General News
Advertisement

Merrimack Pharmaceuticals, Inc.

Selected Balance Sheet Data (unaudited)

(in thousands)

March 31, 2019

December 31, 2018

Cash, cash equivalents and marketable securities

$                    58,466

$                    71,278

Working capital

51,880

61,307

Total assets

74,353

88,543

Total liabilities

25,389

29,724

Total stockholders' equity

48,964

58,819

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close